EUCTR2009-017153-35-DE进行中（未招募）不适用
An international, multi-center, randomized, controlled trial evaluating the effect of xenon on post-operative delirium in elderly patients undergoing hip fracture surgery. - Hip fracture surgery in elderly patients
AIR LIQUIDE SANTE INTERNATIONA0 个研究点目标入组 256 人开始时间: 2010年3月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 256
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Elderly patient (= 75 years).
- •- Patients with planned hip fracture surgery within 48 hours after the hip fracture.
- •- Patient willing and able to complete the requirements of this study including the signature of the written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 256
排除标准
- •- Patient suffering of multiple fractures, pelvic fractures proximal, pathological fractures, femur fractures (ie fracture of the middle and distal femur).
- •- Disabling neuropsychiatric disorders (severe dementia, Alzheimer’s disease, schizophrenia, depression).
- •- Brain trauma within 12 months prior to selection, history of stroke with residuals.
- •- Patient suffering from delirium (CAM diagnosis) at selection.
- •- Patients who cannot complete the pre-operative mental tests of this current clinical trial
- •- Patients with Mini-Mental State Examination (MMSE) score < 24 at selection.
- •- Contra-indication (serious illness or medical conditions) for general anaesthesia .
- •- Known allergy or hypersensitivity to any drugs administered during the current clinical trial.
- •- Previous participation in this current clinical trial.
- •- Participation in another clinical trial within 4 weeks prior to selection.
- •- History of alcohol or drug abuse or psychiatric disorders which would impair the understanding of the necessary information or render medically or legally unable to give written informed consent.
- •- Patient known to susceptible to malignant hyperthermia.
- •- Patient with elevated intra-cranial pressure.
- •- Patient with a risk of high oxygen demand.
- •- Patient with recent or ongoing myocardial infarction / damage.
- •- Patient with severe cardiac failure, or patient with severe impaired left ventricular systolic function.
- •- Patient with known severe lung and/or airway disease, or severe chronic respiratory insufficiency, or a sustained homecare oxygen therapy.
研究者
相似试验
进行中（未招募）
不适用
Hip fracture surgery in elderly patientsPost-operative delirium after hip fracture surgery under general anaesthesiaMedDRA version: 16.1Level: PTClassification code 10020100Term: Hip fractureSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2009-017153-35-GBAIR LIQUIDE SANTE INTERNATIONA256
进行中（未招募）
不适用
Hip fracture surgery in elderly patientsPost-operative delirium after hip fracture surgery under general anaesthesiaMedDRA version: 16.1Level: PTClassification code 10020100Term: Hip fractureSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2009-017153-35-BEAIR LIQUIDE SANTE INTERNATIONA256
进行中（未招募）
不适用
An international, multi-center, randomized, controlled trial evaluating the effect of xenon on postoperative delirium in elderly patients undergoing hip fracture surgery. - Hip fracture surgery in elderly patientsEUCTR2009-017153-35-ITAIR LIQUIDE SANTE` INTERNATIONA256
进行中（未招募）
1 期
An international, multi-center, randomized, controlled trial evaluating the effect of xenon on post-operative delirium in elderly patients undergoing hip fracture surgery. - Hip fracture surgery in elderly patientsPost-operative delirium after hip fracture surgery under general anaesthesiaMedDRA version: 12.1Level: LLTClassification code 10020100Term: Hip fractureEUCTR2009-017153-35-FRAIR LIQUIDE SANTE INTERNATIONA268
进行中（未招募）
1 期
Efficacy and safety of rivaroxaban in reducing the risk of major thrombotic vascular events in subjects with peripheral artery disease undergoing peripheral revascularization procedures of the lower extremities.Peripheral artery diseaseMedDRA version: 18.0 Level: LLT Classification code 10053375 Term: Peripheral revascularization System Organ Class: 100000004865EUCTR2014-005569-58-FRBayer HealthCare AG6,500